Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis

被引:42
作者
Tonello, F
Naletto, L
Romanello, V
Dal Molin, F
Montecucco, C
机构
[1] Univ Padua, CNR, Ist Neurosci, I-35121 Padua, Italy
[2] Univ Padua, Dipartimento Sci Biomed, I-35121 Padua, Italy
关键词
anthrax lethal factor; metalloprotease active site; site-directed mutagenesis; zinc coordination; mitogen-activated protein kinase kinase; peptide substrate; macrophage; Fischer rat; action mechanism;
D O I
10.1016/j.bbrc.2003.11.134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lethal factor (LF) of Bacillus anthracis is a Zn2+-endopeptidase specific for the MAPK-kinase family of proteins. The catalytic zinc atom is coordinated by a first shell of residues including the two histidines and the glutamate of the zinc-binding motif HExxH and by Glu-735. A characteristic feature of LF is the presence, within the second shell of residues, of a tyrosine (Tyr-728) in close proximity (3.3 Angstrom) to the zinc atom. To investigate the role of Tyr-728 and Glu-735, LF mutants with one or both of these two residues replaced by Ala were cloned, expressed, and purified from Escherichia coli. A fourth mutant was obtained by replacing Tyr-728 with Phe. Spectroscopic analysis of these mutants indicates that they fold in the same way as the parental molecule and that zinc stabilizes the structure of LF. These mutants have neither proteolytic activity nor in vivo toxicity. The possible role of Tyr-728 in catalysis is discussed. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 26 条
  • [1] ARORA N, 1993, J BIOL CHEM, V268, P3334
  • [2] Identification of the cellular receptor for anthrax toxin
    Bradley, KA
    Mogridge, J
    Mourez, M
    Collier, RJ
    Young, JAT
    [J]. NATURE, 2001, 414 (6860) : 225 - 229
  • [3] CONSTRUCTION AND CHARACTERIZATION OF A PROTECTIVE ANTIGEN-DEFICIENT BACILLUS-ANTHRACIS STRAIN
    CATALDI, A
    LABRUYERE, E
    MOCK, M
    [J]. MOLECULAR MICROBIOLOGY, 1990, 4 (07) : 1111 - 1117
  • [4] Anthrax
    Dixon, TC
    Meselson, M
    Guillemin, J
    Hanna, PC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) : 815 - 826
  • [5] Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
    Duesbery, NS
    Webb, CP
    Leppla, SH
    Gordon, VM
    Klimpel, KR
    Copeland, TD
    Ahn, NG
    Oskarsson, MK
    Fukasawa, K
    Paull, KD
    Vande Woude, GF
    [J]. SCIENCE, 1998, 280 (5364) : 734 - 737
  • [6] IMMUNOELECTROPHORETIC ANALYSIS, TOXICITY, AND KINETICS OF INVITRO PRODUCTION OF THE PROTECTIVE ANTIGEN AND LETHAL FACTOR COMPONENTS OF BACILLUS-ANTHRACIS TOXIN
    EZZELL, JW
    IVINS, BE
    LEPPLA, SH
    [J]. INFECTION AND IMMUNITY, 1984, 45 (03) : 761 - 767
  • [7] FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123
  • [8] Lethal factor active-site mutations affect catalytic activity in vitro
    Hammond, SE
    Hanna, PC
    [J]. INFECTION AND IMMUNITY, 1998, 66 (05) : 2374 - 2378
  • [9] HANNA PC, 1994, MOL MED, V1, P7
  • [10] Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-α
    Kim, SO
    Jing, Q
    Hoebe, K
    Beutler, B
    Duesbery, NS
    Han, JH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) : 7413 - 7421